These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32056667)

  • 1. Transcriptional profiling indicates cAMP-driven reversal of HIV latency in monocytes occurs via transcription factor SP-1.
    Moar P; Sushmita K; Kateriya S; Tandon R
    Virology; 2020 Mar; 542():40-53. PubMed ID: 32056667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea and interleukin-6 synergistically reactivate HIV-1 replication in a latently infected promonocytic cell line via SP1/SP3 transcription factors.
    Oguariri RM; Brann TW; Imamichi T
    J Biol Chem; 2007 Feb; 282(6):3594-604. PubMed ID: 17150965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch.
    Venkatachari NJ; Zerbato JM; Jain S; Mancini AE; Chattopadhyay A; Sluis-Cremer N; Bar-Joseph Z; Ayyavoo V
    Retrovirology; 2015 Oct; 12():85. PubMed ID: 26438393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency.
    Telwatte S; Morón-López S; Aran D; Kim P; Hsieh C; Joshi S; Montano M; Greene WC; Butte AJ; Wong JK; Yukl SA
    Retrovirology; 2019 Nov; 16(1):32. PubMed ID: 31711503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum deprivation/starvation leads to reactivation of HIV-1 in latently infected monocytes via activating ERK/JNK pathway.
    Raja R; Lata S; Trivedi S; Banerjea AC
    Sci Rep; 2018 Sep; 8(1):14496. PubMed ID: 30262819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Chromatin-Modifying Treatments Reactivate Latent HIV and Decrease Migration of Multiple Host-Cell Types.
    Blanco A; Mahajan T; Coronado RA; Ma K; Demma DR; Dar RD
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34201394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
    Krishnan V; Zeichner SL
    J Virol; 2004 Sep; 78(17):9458-73. PubMed ID: 15308739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underlying mechanisms of HIV-1 latency.
    Romani B; Allahbakhshi E
    Virus Genes; 2017 Jun; 53(3):329-339. PubMed ID: 28258391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1.
    Gohda J; Suzuki K; Liu K; Xie X; Takeuchi H; Inoue JI; Kawaguchi Y; Ishida T
    Sci Rep; 2018 Feb; 8(1):3521. PubMed ID: 29476067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
    Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b.
    Liang T; Zhang X; Lai F; Lin J; Zhou C; Xu X; Tan X; Liu S; Li L
    Biochem Pharmacol; 2019 Jun; 164():237-251. PubMed ID: 30991051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
    Rochat MA; Schlaepfer E; Speck RF
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
    Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T
    EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
    Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic reactivation of latent HIV-1 provirus by PKA activator dibutyryl-cAMP in combination with an HDAC inhibitor.
    Lim H; Kim KC; Son J; Shin Y; Yoon CH; Kang C; Choi BS
    Virus Res; 2017 Jan; 227():1-5. PubMed ID: 27677464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological suppression of glycogen synthase kinase-3 reactivates HIV-1 from latency via activating Wnt/β-catenin/TCF1 axis in CD4
    Wen J; Li X; Zhao QX; Yang XF; Wu ML; Yan Q; Chang J; Wang H; Jin X; Su X; Deng K; Chen L; Wang JH
    Emerg Microbes Infect; 2022 Dec; 11(1):391-405. PubMed ID: 34985411
    [No Abstract]   [Full Text] [Related]  

  • 19. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
    Darcis G; Kula A; Bouchat S; Fujinaga K; Corazza F; Ait-Ammar A; Delacourt N; Melard A; Kabeya K; Vanhulle C; Van Driessche B; Gatot JS; Cherrier T; Pianowski LF; Gama L; Schwartz C; Vila J; Burny A; Clumeck N; Moutschen M; De Wit S; Peterlin BM; Rouzioux C; Rohr O; Van Lint C
    PLoS Pathog; 2015 Jul; 11(7):e1005063. PubMed ID: 26225566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents.
    Petravic J; Rasmussen TA; Lewin SR; Kent SJ; Davenport MP
    J Virol; 2017 May; 91(9):. PubMed ID: 28202759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.